Home / ABHD13 Knockout Cell Lines

ABHD13 Knockout Cell Lines

Gene: ABHD13

Official Full Name: abhydrolase domain containing 13provided by HGNC

Gene Summary: Predicted to enable palmitoyl-(protein) hydrolase activity. Predicted to be involved in lipid metabolic process and protein depalmitoylation. Located in membrane. [provided by Alliance of Genome Resources, Apr 2025]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO24425 ABHD13 Knockout cell line (HeLa) Human ABHD13 1:3~1:6 Negative Online Inquiry
KO24426 ABHD13 Knockout cell line (HCT 116) Human ABHD13 1:2~1:4 Negative Online Inquiry
KO24427 ABHD13 Knockout cell line (HEK293) Human ABHD13 1:3~1:6 Negative Online Inquiry
KO24428 ABHD13 Knockout cell line (A549) Human ABHD13 1:3~1:4 Negative Online Inquiry

Background

ABHD13 Gene Knockout Cell Lines are genetically modified cell lines designed to investigate the biological functions of the ABHD13 gene, which encodes for an enzyme involved in lipid signaling pathways. By completely abrogating the expression of ABHD13, these knockout cell lines provide a crucial tool for researchers to study the role of this gene in various physiological and pathological processes, particularly in the context of adipocyte function, energy homeostasis, and tumor biology.

The functionality of ABHD13 Gene Knockout Cell Lines lies in their ability to facilitate loss-of-function studies and high-throughput screening assays, thereby allowing researchers to uncover the specific contributions of ABHD13 to lipid metabolism and its downstream effects on cellular signaling. These cell lines can be utilized in various experimental settings, including drug discovery, metabolic research, and cancer biology, enabling scientists to explore the underlying mechanisms of diseases related to aberrant lipid signaling.

The importance of ABHD13 in modulating fatty acid profiles and its potential links to metabolic disorders underline the scientific significance of these knockout cell lines. Their application can lead to novel insights that could inform therapeutic strategies targeting lipid metabolism and metabolic dysfunction, underscoring their relevance in both research and clinical contexts.

Compared to alternative models, ABHD13 Gene Knockout Cell Lines offer specific advantages such as precise gene editing efficiency, reproducibility, and a consistent cellular environment, which enhance experimental reliability. Furthermore, these cell lines allow for the investigation of gene function in a controlled manner, paving the way for more targeted research outcomes.

For researchers and clinicians invested in metabolic research and drug development, these knockout cell lines represent a valuable asset. They can elucidate the complexities of lipid signaling and metabolic dysregulation, ultimately contributing to breakthroughs in understanding and treating various diseases.

Our company specializes in high-quality biological tools, including genetically engineered cell lines, and we are committed to advancing research that leads to impactful scientific discoveries. With our expertise in gene editing technology, we provide researchers with reliable, rigorously validated products that facilitate innovative research endeavors.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.